Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency

被引:19
|
作者
Chinwong, Dujrudee [1 ,2 ]
Patumanond, Jayanton [3 ]
Chinwong, Surarong [1 ]
Siriwattana, Khanchai [4 ]
Gunaparn, Siriluck [5 ]
Hall, John Joseph [6 ]
Phrommintikul, Arintaya [5 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Pharmaceut Care, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Med, Clin Epidemiol Program, Chiang Mai 50200, Thailand
[3] Thammasat Univ, Fac Med, Ctr Excellence Appl Epidemiol, Pathum Thani, Thailand
[4] Nakornping Hosp, Div Med, Chiang Mai, Thailand
[5] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50200, Thailand
[6] Univ Newcastle, Fac Hlth, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Callaghan, NSW 2308, Australia
关键词
LDL-C goal attainment; statins; potency statins; high risk; propensity score; LIPID-LOWERING TREATMENT; HIGH-RISK; HYPERCHOLESTEROLEMIC PATIENTS; LDL-C; MEDICATION ADHERENCE; CLINICAL-PRACTICE; PROPENSITY SCORE; ACHIEVEMENT; SIMVASTATIN; EZETIMIBE;
D O I
10.2147/TCRM.S75608
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Elevated low-density lipoprotein cholesterol (LDL-C) is associated with an increased risk of coronary artery disease. Current guidelines recommend an LDL-C target of <70 mg/dL (<1.8 mmol/L) for acute coronary syndrome (ACS) patients, and the first-line treatment to lower lipids is statin therapy. Despite current guidelines and the efficacious lipid-lowering agents available, about half of patients at very high risk, including ACS patients, fail to achieve their LDL-C goal. This study assessed LDL-C goal attainment according to use of high and low potency statins in routine practice in Thailand. Methods: A retrospective cohort study was performed by retrieving data from medical records and the electronic hospital database for a tertiary care hospital in Thailand between 2009 and 2011. Included were ACS patients treated with statins at baseline and with follow-up of LDL-C levels. Patients were divided into high or low potency statin users, and the proportion reaching the LDL-C goal of. 70 mg/dL was determined. A Cox proportional hazard model was applied to determine the relationship between statin potency and LDL-C goal attainment. Propensity score adjustment was used to control for confounding by indication. Results: Of 396 ACS patients (60% males, mean age 64.3 +/- 11.6 years), 229 (58%) were treated with high potency statins and 167 (42%) with low potency statins. A quarter reached their target LDL-C goal (25% for patients on high potency statins and 23% on low potency statins). High potency statins were not associated with increased LDL-C goal attainment (adjusted hazards ratio 1.22, 95% confidence interval 0.79-1.88; P=0.363). Conclusion: There was no significant effect of high potency statins on LDL-C goal attainment. Moreover, this study showed low LDL-C goal attainment for patients on either low or high potency statins. The reasons for the low LDL-C goal attainment rate warrants further investigation.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 50 条
  • [41] Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)
    Andrea Schwarz
    Ilja Demuth
    Ulf Landmesser
    Arash Haghikia
    Maximilian König
    Elisabeth Steinhagen-Thiessen
    Lipids in Health and Disease, 21
  • [42] Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
    Bardolia, Chandni
    Amin, Nishita Shah
    Turgeon, Jacques
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [43] Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry
    Schmidt, Nina
    Dressel, Alexander
    Grammer, Tanja B.
    Gouni-Berthold, Ioanna
    Julius, Ulrich
    Kassner, Ursula
    Klose, Gerald
    Koenig, Christel
    Koenig, Wolfgang
    Otte, Britta
    Parhofer, Klaus G.
    Reinhard, Wibke
    Schatz, Ulrike
    Schunkert, Heribert
    Steinhagen-Thiessen, Elisabeth
    Vogt, Anja
    Laufs, Ulrich
    Maerz, Winfried
    ATHEROSCLEROSIS, 2018, 277 : 314 - 322
  • [44] Long-Term Effect of Ezetimibe-Plus-Statin vs Double-Dose Statin on Low-Density Lipoprotein Cholesterol Lowering in Coronary Artery Disease Patients Pre-Treated with a Statin; Focus on Cholesterol Absorption and Synthesis
    Okada, Kozo
    Kimura, Kazuo
    Iwahashi, Noriaki
    Endo, Tsutomu
    Himeno, Hideo
    Fukui, Kazuki
    Kobayashi, Shunichi
    Shimizu, Makoto
    Iwasawa, Yuji
    Morita, Yukiko
    Wada, Atsushi
    Shigemasa, Tomohiko
    Mochida, Yasuyuki
    Shimizu, Tomoaki
    Sawada, Reimin
    Uchino, Kazuaki
    Umemura, Satoshi
    CIRCULATION, 2011, 124 (21)
  • [45] Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis
    Sun, Haixia
    Yuan, Yang
    Wang, Pin
    Cai, Rongrong
    Xia, Wenqing
    Huang, Rong
    Wang, Shaohua
    LIPIDS IN HEALTH AND DISEASE, 2015, 14
  • [46] Effect of statin therapy on the prevention of new-onset acute coronary syndrome in patients with rheumatoid arthritis
    Huang, Chen-Yu
    Lin, Ting-Tse
    Yang, Yao-Hsu
    Lin, Lian-Yu
    Tsai, Chia-Ti
    Hwang, Juey-Jen
    Chen, Pau-Chung
    Lin, Jiunn-Lee
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 253 : 1 - 6
  • [47] Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis
    Haixia Sun
    Yang Yuan
    Pin Wang
    Rongrong Cai
    Wenqing Xia
    Rong Huang
    Shaohua Wang
    Lipids in Health and Disease, 14
  • [48] Low-density lipoprotein cholesterol of less than 70 mg/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real-life cohort in Thailand
    Chinwong, Dujrudee
    Patumanond, Jayanton
    Chinwong, Surarong
    Siriwattana, Khanchai
    Gunaparn, Siriluck
    Hall, John Joseph
    Phrommintikul, Arintaya
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 659 - 667
  • [49] Sex Difference in Control of Low-Density Lipoprotein Cholesterol in Older Patients after Acute Coronary Syndrome
    Tan Van Nguyen
    Dieu Thi Thanh Tran
    Trinh Thi Kim Ngo
    Tu Ngoc Nguyen
    GERIATRICS, 2022, 7 (04)
  • [50] Effects of Combined Lipid-Lowering Therapy on Low-Density Lipoprotein Cholesterol Variability and Cardiovascular Adverse Events in Patients with Acute Coronary Syndrome
    Tan, Huilian
    Liu, Ling
    Zheng, Qinghou
    Zhang, Dahong
    Liu, Qian
    Cui, Dong
    Gao, Lei
    Wang, Zhen
    Wang, Wen-Lei
    Liu, Jun
    ADVANCES IN THERAPY, 2021, 38 (06) : 3389 - 3398